Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 65.37782 on 17-04-2026 at 18:50:04
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 479.00 at 67.14992
Day's Volume: 202,119
Last Close: 65.37782
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 31.89103 - 72.42
Market Capitalisation: -
VWAP: 66.91263
Shares in Issue: 432.69m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 479 67.14992 OTC Trade
18:44:46 - 17-Apr-26
Unknown* 30 64.92764 OTC Trade
18:28:38 - 17-Apr-26
Unknown* 1,300 66.382 OTC Trade
17:35:28 - 17-Apr-26
Unknown* 25 67.1588 OTC Trade
17:27:53 - 17-Apr-26
Unknown* 329 67.16 OTC Trade
17:25:30 - 17-Apr-26
Unknown* 91 64.81 OTC Trade
17:21:27 - 17-Apr-26
Unknown* 151 65.37782 SI Trade
Negotiated Trade
17:13:32 - 17-Apr-26
Unknown* 285 65.37782 SI Trade
Negotiated Trade
17:13:32 - 17-Apr-26
Unknown* 25 66.2581 OTC Trade
17:10:27 - 17-Apr-26
Unknown* 14,965 66.02189 OTC Trade
17:07:11 - 17-Apr-26
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Apr 2026 (Fri) 65.37782 65.37782 65.37782 65.37782 202,119
16th Apr 2026 (Thu) 66.68 66.68 66.68 66.68 115,102
15th Apr 2026 (Wed) 67.98909 67.98909 67.98909 67.98909 752,959
14th Apr 2026 (Tue) 67.50372 67.50372 67.50372 67.50372 40,524
13th Apr 2026 (Mon) 65.4265 65.4265 65.4265 65.4265 88,827
10th Apr 2026 (Fri) 66.645 66.645 66.645 66.645 93,736
9th Apr 2026 (Thu) 64.58611 64.58611 64.58611 64.58611 48,258
8th Apr 2026 (Wed) 65.116 65.116 65.116 65.116 92,561
7th Apr 2026 (Tue) 63.955 63.955 63.955 63.955 83,048
6th Apr 2026 (Mon) 63.50 63.50 63.50 63.50 0
3rd Apr 2026 (Fri) 63.50 63.50 63.50 63.50 0
2nd Apr 2026 (Thu) 63.50 63.50 63.50 63.50 100,800
1st Apr 2026 (Wed) 64.33052 64.33052 64.33052 64.33052 926,899
31st Mar 2026 (Tue) 61.71333 61.71333 61.71333 61.71333 1,789,632
30th Mar 2026 (Mon) 60.56533 60.56533 60.56533 60.56533 36,980
27th Mar 2026 (Fri) 60.28042 60.28042 60.28042 60.28042 45,259
26th Mar 2026 (Thu) 60.62038 60.62038 60.62038 60.62038 30,530
25th Mar 2026 (Wed) 61.31814 61.31814 61.31814 61.31814 58,525
24th Mar 2026 (Tue) 59.69727 59.69727 59.69727 59.69727 98,701
23rd Mar 2026 (Mon) 60.0411 60.0411 60.0411 60.0411 39,016
20th Mar 2026 (Fri) 60.95742 60.95742 60.95742 60.95742 440,981
19th Mar 2026 (Thu) 60.96525 60.96525 60.96525 60.96525 386,432
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value10,667.63
Change77.64

Login to your account

Forgot Password?

Not Registered